Related Experiment Video
Updated: Aug 29, 2026

Surgically Induced Cardiac Volume Overload by Aortic Regurgitation in Mouse
Published on: August 30, 2022
Increased prevalence of regurgitant valvular heart disease in acromegaly
Alberto M Pereira1, Sjoerd W van Thiel, Jonathan R Lindner
1Department of Endocrinology and Metabolism, Leiden University Medical Center, 2300 RC Leiden, The Netherlands. a.m.pereira@lumc.nl
Insights
Acromegaly significantly increases the risk of valvular heart disease, particularly aortic and mitral regurgitation. This risk grows with disease duration, highlighting the need for vigilant monitoring in affected patients.
Area of Science:
- Cardiology
- Endocrinology
Background:
- Cardiac involvement is a known complication of acromegaly.
- The prevalence of valvular abnormalities in acromegaly patients remains undocumented.
Purpose of the Study:
- To investigate the prevalence of valvular abnormalities in patients with acromegaly.
- To compare valvular disease rates between acromegaly patients and matched controls.
Main Methods:
- Prospective study design.
- Involved 40 acromegaly patients and 120 controls matched for age, sex, hypertension, and left ventricular systolic function.
- Utilized conventional two-dimensional and Doppler echocardiography for evaluation.
Main Results:
- Significant valve disease was more prevalent in acromegaly patients (22%) compared to controls (6.7%; P = 0.005).
- Aortic valve regurgitation was observed in 30% of patients versus 7% of controls (P < 0.001).
- Mitral regurgitation was present in 5% of acromegaly patients but absent in controls (P = 0.014).
- Disease duration was the sole significant predictor, with a 19% increased odds of valvular disease per year of exposure to elevated growth hormone (GH) concentrations.
Conclusions:
- Acromegaly is associated with a higher prevalence of regurgitant valvular heart disease.
- The risk of valvular disease is directly related to the duration of exposure to excess GH.
- Patients with acromegaly require diligent monitoring for occult valvular disease, especially those with uncontrolled GH overproduction.
Abstract:
Cardiac involvement is common in acromegaly, but the prevalence of valvular abnormalities in patients with acromegaly has not been documented and is the topic of this study. In a prospective study design, 40 consecutive patients with acromegaly and 120 control subjects (matched for age, sex, hypertension, and left ventricular systolic function) were studied. All patients and controls were evaluated using conventional two-dimensional and Doppler echocardiography. Significant valve disease was more prevalent in acromegalics compared with controls (22% vs. 6.7%, respectively; P = 0.005). Aortic valve regurgitation (>/=>trace severity) was present in 30% of patients vs. 7% of controls (P < 0.001), and mitral regurgitation (>/=moderate severity) was absent in controls but present in 5% of acromegalics (P = 0.014 vs. controls). Binary logistic regression analysis showed a significant impact only for disease duration on valvular disease, with an odds ratio of 1.19 (95% confidence interval, 1.028-1.376; P = 0.019). Acromegaly is associated with an increased prevalence of regurgitant valvular heart disease. This is dependent on the duration of exposure to increased GH concentrations, with a 19% increase in odds per year. This increased prevalence of occult valvular disease indicates that these patients require appropriate follow-up care and monitoring, especially patients with inadequate control of GH overproduction.
More Related Videos
Related Concept Videos
Mitral Regurgitation I: Introduction
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Valve Prolapse I: Introduction
Aortic Regurgitation III: Medical Management
Mitral Stenosis I: Introduction

